Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY) in Hospitalized Children With RSV
Status:
RECRUITING
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
THAI-CARES RSV Study is a Phase II, open-label, multicenter, randomized controlled trial with a two-arm, parallel-group design. The study aims to assess the safety, efficacy, and acceptability of a five-day course of Remdesivir (VEKLURY) in children under two years of age who are hospitalized with confirmed respiratory syncytial virus (RSV) infection, as determined by either a rapid antigen test or RT-PCR. The primary objectives include evaluating the treatment's safety profile, its ability to significantly reduce RSV replication, and its overall acceptance in this patient population.
Phase:
PHASE2
Details
Lead Sponsor:
PENTA Foundation
Collaborators:
AMS-PHPT Research Collaboration Chiang Mai University Hospital Universitario 12 de Octubre